🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary objectives are to: 1. Evaluate the safety and tolerability of ...
Status
Completed
Location
Central Brisbane Dermatology
Start Date
2020-07-16
Trial ID
NCT04416516
Treatments Being Tested
This is a randomized open label study to evaluate the long term safety of A...
Status
Terminated
Location
Pinnacle Research Group, LLC
Start Date
2018-09-29
Trial ID
NCT03654755
Treatments Being Tested
This study is a dose escalation, and cohort expansion study in subjects wit...
Status
Terminated
Location
Arizona Oncology
Start Date
2015-05
Trial ID
NCT02440685
Treatments Being Tested
The study evaluates whether ASN-002 is safe and effective in the treatment ...
Status
Completed
Location
St George Dermatology and Skin Cancer Centre
Start Date
2015-09
Trial ID
NCT02550678
The primary objective is to confirm the safety of treating multiple BCCs on...
Status
Suspended
Location
OHSU
Start Date
2017-12-01
Trial ID
NCT03208296
Treatments Being Tested
Randomized double-blind/placebo study to evaluate the efficacy of ASN002 in...
Status
Completed
Location
Pinnacle Research Group, LLC
Start Date
2019-01-03
Trial ID
NCT03728504
Treatments Being Tested
This is a randomized double-blind/placebo study evaluate the efficacy of AS...
Status
Completed
Location
Pinnacle Research Group, LLC
Start Date
2018-07-05
Trial ID
NCT03531957
Treatments Being Tested
Phase 1, Open-label Study of the Absorption, Metabolism, and Excretion of \...
Status
Completed
Location
Covance Clinical Research Unit
Start Date
2018-10-11
Trial ID
NCT03641573
Treatments Being Tested
The purpose of this study is to evaluate the safety and tolerability, and d...
Status
Completed
Location
InVentiv Health
Start Date
2016-07
Trial ID
NCT02853643
Treatments Being Tested
This is a dose escalation study to test the safety, tolerability and prelim...
Status
Completed
Location
Center for Dermatology Clinical Research, Inc.
Start Date
2017-04-12
Trial ID
NCT03139981
Treatments Being Tested